GKB Ophthalmics Limited (BOM:533212)
India · Delayed Price · Currency is INR 64.84
+1.14 (1.79%)
At close: Jun 4, 2026
GKB Ophthalmics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 12.19 | -70.45 | -28.11 | -1.67 | 12.74 |
Depreciation & Amortization | 32.37 | 30.86 | 28.98 | 28.27 | 26.66 |
Other Amortization | - | 0.01 | 0.01 | 0.02 | 0.03 |
Loss (Gain) From Sale of Assets | -0.76 | -0.4 | -0.45 | -0.57 | 0.42 |
Loss (Gain) From Sale of Investments | 0.01 | - | - | - | -0.07 |
Loss (Gain) on Equity Investments | 0.59 | -1.83 | 0.59 | -0.33 | -0.91 |
Provision & Write-off of Bad Debts | -0.06 | 52.27 | 1.52 | 0.78 | -0.64 |
Other Operating Activities | 30.32 | 14.5 | 6.87 | 12.13 | 15.65 |
Change in Accounts Receivable | -218.54 | -25.82 | -8.26 | -84.75 | -0.02 |
Change in Inventory | -42.53 | -103.59 | -12.79 | -10.36 | -22.93 |
Change in Accounts Payable | 145.74 | 59.76 | 94.68 | -18.42 | 17.22 |
Change in Other Net Operating Assets | 2.61 | 10.38 | -40.83 | 47.16 | 2.53 |
Operating Cash Flow | -38.07 | -34.3 | 42.21 | -27.74 | 50.69 |
Operating Cash Flow Growth | - | - | - | - | -26.07% |
Capital Expenditures | -10.27 | -21.47 | -20.76 | -12.13 | -47.58 |
Sale of Property, Plant & Equipment | 1.28 | 0.4 | 0.5 | 22 | 1.29 |
Investment in Securities | 85.5 | 37.62 | -25.14 | -16.27 | 9.85 |
Other Investing Activities | 13.48 | 8.95 | 28.28 | 20.69 | 1.2 |
Investing Cash Flow | 89.98 | 25.5 | -17.13 | 14.29 | -35.25 |
Short-Term Debt Issued | - | - | 3.42 | 0.26 | - |
Long-Term Debt Issued | 53.3 | 44.1 | 4.42 | - | 9.95 |
Total Debt Issued | 53.3 | 44.1 | 7.84 | 0.26 | 9.95 |
Short-Term Debt Repaid | -22.92 | -5.09 | - | - | -6.98 |
Long-Term Debt Repaid | -58.79 | -8.92 | -5.12 | -5.65 | -5.15 |
Total Debt Repaid | -81.71 | -14.01 | -5.12 | -5.65 | -12.12 |
Net Debt Issued (Repaid) | -28.41 | 30.09 | 2.72 | -5.39 | -2.17 |
Common Dividends Paid | - | - | - | -0.01 | - |
Other Financing Activities | -27.05 | -23.4 | -19.11 | -16.45 | -14.47 |
Financing Cash Flow | -55.46 | 6.69 | -16.4 | -21.85 | -16.64 |
Net Cash Flow | -3.54 | -2.11 | 8.68 | -35.3 | -1.2 |
Free Cash Flow | -48.34 | -55.77 | 21.44 | -39.87 | 3.11 |
Free Cash Flow Growth | - | - | - | - | -40.65% |
Free Cash Flow Margin | -3.19% | -5.12% | 2.43% | -5.28% | 0.44% |
Free Cash Flow Per Share | -9.60 | -11.06 | 4.25 | -7.91 | 0.62 |
Cash Interest Paid | - | 23.4 | 19.11 | 16.45 | 14.47 |
Cash Income Tax Paid | - | 1.36 | 1.86 | 1.65 | 0.76 |
Levered Free Cash Flow | -11.7 | -48.17 | 24.03 | -58.66 | -25.97 |
Unlevered Free Cash Flow | 5.02 | -38.34 | 32.68 | -50.56 | -19.01 |
Change in Working Capital | -112.72 | -59.26 | 32.79 | -66.37 | -3.2 |